NARDIN, CHIARA

NARDIN, CHIARA  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Blood Pressure Variability and Therapeutic Implications in Hypertension and Cardiovascular Diseases 2019 Nardin C.Rattazzi M.Pauletto P. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION - -
L-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells 2020 Rattazzi M.Donato M.Bertacco E.Millioni R.Franchin C.Mortarino C.Faggin E.Nardin C.Scarpa R.Cinetto F.Agostini C.Ferri N.Pauletto P.Arrigoni G. ATHEROSCLEROSIS - -
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice 2021 Puato, MassimoZambon, AlbertoNardin, ChiaraFaggin, ElisabettaSpinazzè, AlicePauletto, PaoloRattazzi, Marcello + CARDIOVASCULAR THERAPEUTICS - -
Serum uric acid levels and the risk of recurrent venous thromboembolism 2021 De Lucchi L.Nardin C.Sponchiado A.Faggin E.Plebani M.Pauletto P.Cinetto F.Agostini C.Rattazzi M. + JOURNAL OF THROMBOSIS AND HAEMOSTASIS - -
Subclinical Cardiovascular Damage in Systemic Rheumatic Diseases 2017 Nardin, C.Rattazzi, M.Pauletto, P. - - Handbook of Systemic Autoimmune Diseases
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives 2020 Felice, CNardin, CGrossi, UScaldaferri, LCavasin, PScarpa, RFarnia, ARigoli, RCinetto, FPauletto, PAgostini, CRattazzi, M + AMERICAN JOURNAL OF HYPERTENSION - -
Vascular remodelling in well-controlled hypertensive patients: the challenge of residual risk management 2017 PUATO, MASSIMONARDIN, CHIARAZANON, MARTAPALATINI, PAOLOPAULETTO, PAOLORATTAZZI, MARCELLO CURRENT PHARMACEUTICAL DESIGN - -
Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice 2018 Rattazzi MFaggin EBertacco ENardin CPlebaniCinetto FGuidolin D4Puato MPauletto P + CARDIOVASCULAR THERAPEUTICS - -